Searche

Your search for "integrity" matched 111 page(s).

Showing results 71 to 80.

Attribution, advocacy, disposable authors, corporate ghosts and cultural assimilation: new themes in the ethical critique of commercial medical literature - Volume 25, Issue

This interview provides solutions to some of the common pitfalls that face medical writers when working with large teams. Practical tips are provided on key topics including manuscript planning, agreeing on key messages and the use of figures,…

The Crofter: Sustainable Communications - Volume 32, Issue

Sustainable supply As medical writers/ communicators who provide services to pharmaceutical companies, we are part of a pharmaceutical company’s supply chain. In this issue, we follow-up on EMWA’s November 2022 Expert Series Seminar (ESS) on…

Medical education in a medcomms agency - Volume 25, Issue

Medcomms agencies provide services and counselling to pharmaceutical clients in many ways. Medcomms are currently strengthening medical education as a form of indirect communication strategy, which focuses on educating health professionals on…

President's Message - Volume 32, Issue

A look forward – and back! - at AI in Medical Writing This issue of Medical Writing is devoted to automation and artificial intelligence (AI), the hot topic that interests all of us and that is likely to change our lives dramatically, at least our…

News from the EMA - Volume 30, Issue

February 26, 2021 – EMA has recommended granting a marketing authorisation in the European Union (EU) for the first treatment that can be given orally to patients with certain types of spinal muscular atrophy (SMA), a rare and often fatal genetic…

Regulatory Writing Briefing documents: A case apart - Volume 24, Issue

Health authority briefing documents (also known as briefing packs, briefing packages, and briefing books) are documents prepared by a pharmaceutical company to support its interactions (e.g. pre-submission meetings, requests for scientific advice,…

Clinical trial disclosure landscape and awareness in Japan - Volume 28, Issue

While disclosure of individual clinical study reports (CSRs) is becoming common globally, this is not yet the case in Japan, where the national health authority does not require CSRs to be made publicly available. As CSRs of Japanese studies might…

Veterinary Medical Writing - Volume 28, Issue

With veterinary treatment options becoming more diverse and advancing rapidly, the demand for veterinary medical writers is growing. Currently we are a growing group of vets in EMWA and we look forward to welcoming more colleagues to our…

Odd cases and risky cohorts: Measures of risk and association in observational studies - Volume 26, Issue

Hundreds of statistical tests, procedures, and descriptive measures are used in clinical research. Risks, odds, and hazards are among the most common but not always the most understood. They are often used in all three types of observational studies…

Changing methods to assess targeted therapies in oncology - Volume 27, Issue

New methods have been developed to evaluate targeted therapies, since the classic sequence – phase I, toxicity; phase II, efficacy; phase III, comparison with standard treat ment – is no longer effective for evaluating these new treatments. In…

Visit the EMWA website

Search

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Scope

Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.

Medical Writing is listed in the following indexes: